L

LFB

Public health biopharmaceuticals via plasma-derived products

Group Information Systems Security Manager

Full-Time
No salary listed
Senior
Les Ulis, France
HybridUp to two remote-work days per week after four months of employment.
CybersecuritySecurity Governance, Risk & Compliance

About the job

Requirements
  • At least 5 years of experience as an Information Systems Security Manager.
  • A first management experience is mandatory.
Responsibilities
  • Define and implement group, France, and international cybersecurity strategic plans and policies.
  • Protect digital assets, ensure business continuity, maintain trust, and align security with the company's overall strategy.
  • Define governance, communication, and reporting with the Chief Information Officer, executive committee, and business functions.
  • Define and enforce information systems security standards and policies.
  • Analyze information systems risks and threats, including industrial information systems, and assess their potential impacts.
  • Study, build, and validate solutions and processes to proactively and reactively counter security threats.
  • Define and lead security audits, vulnerability testing, and remediation plans, potentially collaborating with red teams.
  • Analyze and handle security incidents, including attacks, theft, and data leaks, implement remediation solutions, and conduct root cause analyses.
  • Maintain mapping of solutions and risks, security architecture, risk analysis, and crisis management.
  • Build and document disaster recovery plans and business continuity plans.
  • Monitor cybersecurity developments and participate in tracking software and hardware obsolescence.
  • Develop secure-by-design practices with information technology teams and business functions.
  • Manage and participate in compliance projects, particularly concerning NIS2, the General Data Protection Regulation, and data integrity.
  • Provide consulting, assistance, information, training, and alerts related to cybersecurity.
  • Act as the technical and functional expert and designated point of contact for the cybersecurity domain.
  • Develop cybersecurity awareness and training programs for users.
  • Ensure application of security management best practices.
  • Facilitate operational and strategic cybersecurity committees.
  • Regularly inform management about cybersecurity needs, strategic-plan progress, and incidents.
  • Define and monitor cybersecurity key performance indicators using dashboards.
  • Manage and develop a direct cybersecurity team and indirect staff, including company teams and service providers.
  • Coordinate projects with legal, human resources, and procurement teams.

About the company

LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Courcebœufs, France

Founded

1994

Get referred to LFB

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Arras released first medicines in 2025, proving commercialization after heavy capital spending.
  • LFB signed a 2026 collaboration with Sartorius to accelerate client programs and GMP manufacturing.
  • France 2030 funding and the 2026 Alès expansion add capacity and roughly fifty jobs.

What critics are saying

  • EFS must raise plasma collections to 1.4 million liters by 2028 or Arras underutilizes.
  • LFB BIOMANUFACTURING still depends on Sartorius for cell line development, limiting full-stack control.
  • A single French industrial base creates existential exposure to contamination, recalls, or regulatory shutdowns.

What makes LFB unique

  • French state-owned sole domestic plasma fractionator anchors national medicine supply.
  • Arras plant, authorized in 2025, centralizes production and triples plasma-derived capacity.
  • Europlasma and Amber Plasma give LFB 24 Central European collection centers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Remote Work Options

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Hybrid Work Options

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

Conference Attendance Budget

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Education allowance

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

8%

2 year growth

7%
MyPharma Editions
May 30th, 2024
LFB Acquires Amber Plasma in Czech Republic

Title: "LFB Acquires Amber Plasma in the Czech Republic" LFB and its subsidiary Europlasma have acquired Amber Plasma, which operates 12 plasma collection centers in the Czech Republic. This acquisition increases Europlasma's total to 24 centers in Central Europe, enhancing LFB's plasma collection capacity. The move supports LFB's goal to meet growing patient demand and will aid in the launch of a new production site in Arras, France, tripling its medication production capacity.